Nepsis Inc’s XPeng XPEV Stock Holding History

Nepsis Inc’s Portfolio XPEV Stock Details XPEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-260,700	Closed	-$11.6M	–	33
2021 Q2	$11.6M	Sell	260,700 -5,900	-2%	-$201K	3.67%	15
2021 Q1	$9.73M	Buy	266,600 +3,051	+1%	+$127K	3.08%	18
2020 Q4	$11.4M	Buy	+263,549	New	+$9.68M	4.13%	9

Other funds holding XPEV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

PCM

Primavera Capital Management George Town, Cayman Islands $648M AUM 6.1% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

AMH

Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Alibaba Group Causeway Bay, Hong Kong $653M AUM 16.11% 1-Year Est. Return

Nepsis Inc's XPEV Position: Q3 2021 in Review

Nepsis Inc sold out of XPeng (XPEV) in Q3 2021, closing a stake of 260,700 shares — an estimated $11.6M sold.

Nepsis Inc first reported a position in XPEV in Q4 2020 and held it in 3 quarters. The position peaked at $11.6M in Q2 2021. 296 funds tracked by Wall St. Rank hold XPEV as of Q3 2021.

Nepsis Inc reported no remaining XPeng position as of Q3 2021 after selling out during the quarter.
Nepsis Inc sold 260,700 XPeng shares in Q3 2021, an estimated $11.6M.
Nepsis Inc first reported a position in XPeng in Q4 2020 and held it in 3 quarters.
Nepsis Inc's XPeng position peaked at $11.6M in Q2 2021.
296 funds tracked by Wall St. Rank held XPeng as of Q3 2021.

Based on Nepsis Inc's 13F filing for Q3 2021, filed 13 Oct 2021.